Mathias Francois

Author PubWeight™ 8.16^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.	J Clin Invest	2014	1.23
2	Tumor lymphangiogenesis as a potential therapeutic target.	J Oncol	2012	0.97
3	Possible genetic predisposition to lymphedema after breast cancer.	Lymphat Res Biol	2012	0.96
4	Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice.	Cancer Res	2012	0.90
5	PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis.	Oncotarget	2013	0.89
6	15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.	FEBS Lett	2004	0.88
7	VEGFD regulates blood vascular development by modulating SOX18 activity.	Blood	2013	0.86
8	Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.	Arthritis Rheum	2005	0.85
9	Cytoplasmic plaque formation in hemidesmosome development is dependent on SoxF transcription factor function.	PLoS One	2012	0.79
10	Tmem2 Regulates Embryonic Vegf Signaling by Controlling Hyaluronic Acid Turnover.	Dev Cell	2017	0.75